Article

A Major Genome Region Underlying Artemisinin Resistance in Malaria

Texas Biomedical Research Institute, San Antonio, TX 78245, USA.
Science (Impact Factor: 31.48). 04/2012; 336(6077):79-82. DOI: 10.1126/science.1215966
Source: PubMed

ABSTRACT Evolving resistance to artemisinin-based compounds threatens to derail attempts to control malaria. Resistance has been confirmed in western Cambodia and has recently emerged in western Thailand, but is absent from neighboring Laos. Artemisinin resistance results in reduced parasite clearance rates (CRs) after treatment. We used a two-phase strategy to identify genome region(s) underlying this ongoing selective event. Geographical differentiation and haplotype structure at 6969 polymorphic single-nucleotide polymorphisms (SNPs) in 91 parasites from Cambodia, Thailand, and Laos identified 33 genome regions under strong selection. We screened SNPs and microsatellites within these regions in 715 parasites from Thailand, identifying a selective sweep on chromosome 13 that shows strong association (P = 10(-6) to 10(-12)) with slow CRs, illustrating the efficacy of targeted association for identifying the genetic basis of adaptive traits.

Download full-text

Full-text

Available from: Rose McGready, Jul 26, 2015
1 Follower
 · 
318 Views
  • Source
    • "In India, its management is challenging due to the country's huge population and large geographical area further compounded by rapid urbanisation (Shah et al. 2011) as well as the resistance developed by the malarial parasite to most of the existing classes of antimalarial drugs (Anderson 2009). Although artemisinin, a sesquiterpene lactone of the Chinese herb Artemisia annua L., and its synthetic analogues are very effective in controlling drug-resistant malaria (White 2008), a recent report indicates the emergence of artemisinin-resistant malarial parasite strains in western Cambodia and western Thailand (Cheeseman et al. 2012). Such wide spectrum drug resistance and the possibility of the existence of regional subpopulations of malarial parasites differing in sensitivity to different classes of drugs necessitates continuing the search for novel antiplasmodial pharmacophores for short-and long-term effective control of malaria (Anderson 2009). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Eighty four different fungal endophytes isolated from sea grasses (5), marine algae (36) and leaves or barks of forest trees (43) were grown in vitro and the secondary metabolites secreted by them were harvested by immobilizing them on XAD beads. These metabolites were eluted with methanol and screened using SYBR Green I assay for their antiplasmodial activity against blood stage Plasmodium falciparum in human red blood cell culture. Our results revealed that fungal endophytes belonging to diverse genera elaborate antiplasmodial metabolites. A Fusarium sp. (580, IC 50 : 1.94 µg ml -1) endophytic in a marine alga and a Nigrospora sp. (151, IC 50 : 2.88 µg ml -1) endophytic in a tree species were subjected to antiplasmodial activity-guided re-versed phase high performance liquid chromatography separation. Purification led to potentiation as reflected in IC 50 values of 0.12 µg ml -1 and 0.15 µg ml -1 for two of the fractions obtained from 580. Our study adds further credence to the notion that fungal endophytes are a potential storehouse for a variety of novel secondary metabolites vested with different bioactivities including some that can stall the growth of the malaria parasite.
    Acta Parasitologica 10/2014; 59(4):745-757. DOI:10.2478/s11686-014-0307-2 · 0.97 Impact Factor
  • Source
    • "We then asked whether EXP1 might be involved in drug action of ART, whose cellular effectors may extend beyond the genes and genomic regions that recent studies associated with emerging ART resistance (Ariey et al., 2014; Cheeseman et al., 2012; Park et al., 2012; Takala-Harrison et al., 2013). Specifically, we tested a model (Mukanganyama et al., 2001) of reductive metabolism of ART, mediated by a hypothetical GST that could catalyze the formation of GSH-ART complexes via GSH binding to the drug's lactone ring to form a hydroperoxide moiety. "
    [Show abstract] [Hide abstract]
    ABSTRACT: A central problem in biology is to identify gene function. One approach is to infer function in large supergenomic networks of interactions and ancestral relationships among genes; however, their analysis can be computationally prohibitive. We show here that these biological networks are compressible. They can be shrunk dramatically by eliminating redundant evolutionary relationships, and this process is efficient because in these networks the number of compressible elements rises linearly rather than exponentially as in other complex networks. Compression enables global network analysis to computationally harness hundreds of interconnected genomes and to produce functional predictions. As a demonstration, we show that the essential, but functionally uncharacterized Plasmodium falciparum antigen EXP1 is a membrane glutathione S-transferase. EXP1 efficiently degrades cytotoxic hematin, is potently inhibited by artesunate, and is associated with artesunate metabolism and susceptibility in drug-pressured malaria parasites. These data implicate EXP1 in the mode of action of a frontline antimalarial drug.
    Cell 08/2014; 158(4):916-28. DOI:10.1016/j.cell.2014.07.011 · 33.12 Impact Factor
  • Source
    • "Characterizing the variation in treatment susceptibility among genotypes of Plasmodium falciparum (the most clinically important human malaria parasite) is challenging as mixed strain infections are common (Juliano et al. 2010), and it is difficult to control other infection variables , not least because untreated controls are not possible for ethical reasons. This makes it challenging to disentangle the relative contribution of the parasite and host factors which generate the substantial variation observed in the infection clearance rates of treated infections in humans (Cheeseman et al. 2012). Susceptibility of P. falciparum parasite lines can be tested in vitro, and substantial genetic variation has been shown in this context (Beez et al. 2011), but it remains unclear how this relates to susceptibility and infection dynamics in the host. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Artemisinin-based drugs are the front-line weapon in the treatment of human malaria cases, but there is concern that recent reports of slow clearing infections may signal developing resistance to treatment. In the absence of molecular markers for resistance, current efforts to monitor drug efficacy are based on the rate at which parasites are cleared from infections. However, some knowledge of the standing variation in parasite susceptibility is needed to identify a meaningful increase in infection half-life. Here, we show that five previously unexposed genotypes of the rodent malaria parasite Plasmodium chabaudi differ substantially in their in vivo response to treatment. Slower clearance rates were not linked to parasite virulence or growth rate, going against the suggestion that drug treatment will drive the evolution of virulence in this system. The level of variation observed here in a relatively small number of genotypes suggests existing ‘resistant’ parasites could be present in the population and therefore, increased parasite clearance rates could represent selection on pre-existing variation rather than de novo resistance events. This has implications for resistance monitoring as susceptibility may depend on evolved traits unrelated to drug exposure.
    Evolutionary Applications 08/2014; 8(3). DOI:10.1111/eva.12194 · 4.57 Impact Factor
Show more